Literature DB >> 11177698

Extrahepatic manifestations of chronic viral hepatitis.

N T Pyrsopoulos1, K R Reddy.   

Abstract

Hepatitis B (HBV) and C (HCV) viruses are well-recognized causes for chronic hepatitis, cirrhosis, and even for hepatocellular carcinoma. Apart from liver disease, these viral infections are known to be associated with a spectrum of extrahepatic manifestations. The prevalence of clinically significant extrahepatic manifestations is relatively low, but it can be associated with significant morbidity and even mortality. An awareness and recognition of these manifestations is of paramount importance in facilitating early diagnosis and in offering treatment. However, treatments are not necessarily effective, and patients may continue with disabling extrahepatic manifestations. Hepatitis B virus has been well recognized as causing a variety of manifestations that include skin rash, arthritis, arthralgia, glomerulonephritis, polyarteritis nodosa, and papular acrodermatitis. More recently, infection with hepatitis C virus has elicited considerable interest for its role in a spectrum of extrahepatic manifestations. Among the best-reported are cryoglobulinemia, glomerulonephritis, high titer of autoantibodies, idiopathic thrombocytopenic purpura, lichen planus, Mooren's corneal ulcer, Sjögren's syndrome, porphyria cutanea tarda, and necrotizing cutaneous vasculitis. The precise pathogenesis of these extrahepatic complications has not been determined, although the majority represent the clinical expression of autoimmune phenomena.

Entities:  

Mesh:

Year:  2001        PMID: 11177698     DOI: 10.1007/s11894-001-0044-1

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  50 in total

Review 1.  Renal involvement in essential mixed cryoglobulinemia.

Authors:  G D'Amico; G Colasanti; F Ferrario; R A Sinico
Journal:  Kidney Int       Date:  1989-04       Impact factor: 10.612

2.  Cryoglobulinaemia and hepatitis C virus.

Authors:  M Casato; G Taliani; L P Pucillo; F Goffredo; B Laganà; L Bonomo
Journal:  Lancet       Date:  1991-04-27       Impact factor: 79.321

Review 3.  Hepatitis C-associated autoimmune disorders.

Authors:  R W McMurray
Journal:  Rheum Dis Clin North Am       Date:  1998-05       Impact factor: 2.670

4.  Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane.

Authors:  B Combes; J Shorey; A Barrera; P Stastny; E H Eigenbrodt; A R Hull; N W Carter
Journal:  Lancet       Date:  1971-07-31       Impact factor: 79.321

5.  Erosive lichen planus and cirrhotic hepatitis.

Authors:  A Rebora; P Patri; E Rampini; F Crovato; G Ciravegna; A Rebora; P O Patri; E Rampini; F Crovato; G Ciravegna
Journal:  Ital Gen Rev Dermatol       Date:  1978 May-Aug

6.  Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha.

Authors:  E Roti; R Minelli; T Giuberti; S Marchelli; C Schianchi; E Gardini; M Salvi; F Fiaccadori; G Ugolotti; T M Neri; L E Braverman
Journal:  Am J Med       Date:  1996-11       Impact factor: 4.965

7.  Primary glomerulonephritis with detectable glomerular hepatitis B virus antigens.

Authors:  F M Lai; K N Lai; J S Tam; S F Lui; K F To; P K Li
Journal:  Am J Surg Pathol       Date:  1994-02       Impact factor: 6.394

8.  Effects of ribavirin on hepatitis C-associated nephrotic syndrome in four liver transplant recipients.

Authors:  H P Pham; C Féray; D Samuel; M Gigou; D Azoulay; V Paradis; F Ducret; B Charpentier; B Debuire; A Lemoine
Journal:  Kidney Int       Date:  1998-10       Impact factor: 10.612

9.  Hepatitis B e antigen-mediated membranous glomerulonephritis. Correlation of ultrastructural changes with HBeAg in the serum and glomeruli.

Authors:  H Ito; S Hattori; I Matusda; S Amamiya; H Hajikano; H Yoshizawa; Y Miyakawa; M Mayumi
Journal:  Lab Invest       Date:  1981-03       Impact factor: 5.662

10.  Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy.

Authors:  R J Johnson; D R Gretch; W G Couser; C E Alpers; J Wilson; M Chung; J Hart; R Willson
Journal:  Kidney Int       Date:  1994-12       Impact factor: 10.612

View more
  33 in total

1.  Extrahepatic manifestations of acute hepatitis B virus infection.

Authors:  Matthew R Kappus; Richard K Sterling
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-02

Review 2.  Viral hepatitis: past and future of HBV and HDV.

Authors:  Emmanuel Thomas; Masato Yoneda; Eugene R Schiff
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-02       Impact factor: 6.915

3.  Pegylated interferon alpha-associated optic neuropathy.

Authors:  Kathleen T Berg; Bruce Nelson; Andrew R Harrison; Linda K McLoon; Michael S Lee
Journal:  J Neuroophthalmol       Date:  2010-06       Impact factor: 3.042

Review 4.  Nonliver Comorbidities in Patients With Chronic Hepatitis B.

Authors:  Mike T Wei; Linda Henry; Mindie H Nguyen
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-10-09

Review 5.  Environmental peer pressure: CD4+ T cell help in tolerance and transplantation.

Authors:  Dana Tedesco; Arash Grakoui
Journal:  Liver Transpl       Date:  2018-01       Impact factor: 5.799

6.  CD4+ Foxp3+ T cells promote aberrant immunoglobulin G production and maintain CD8+ T-cell suppression during chronic liver disease.

Authors:  Dana Tedesco; Manoj Thapa; Sanjeev Gumber; Elizabeth J Elrod; Khalidur Rahman; Chris C Ibegbu; Joseph F Magliocca; Andrew B Adams; Frank Anania; Arash Grakoui
Journal:  Hepatology       Date:  2016-12-19       Impact factor: 17.425

Review 7.  Targeted DNA mutagenesis for the cure of chronic viral infections.

Authors:  Joshua T Schiffer; Martine Aubert; Nicholas D Weber; Esther Mintzer; Daniel Stone; Keith R Jerome
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

8.  Chronic hepatitis B serum promotes apoptotic damage in human renal tubular cells.

Authors:  Cun-Liang Deng; Xin-Wen Song; Hai-Jun Liang; Chen Feng; Yun-Jian Sheng; Ming-Yong Wang
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

9.  The prevalence of HCV antibodies in skin disease patients in Saudi Arabia.

Authors:  Mona Halawani; Amal Balbisi; Hend Alotaibi; Fahed Alsaif; Talal M Bakir
Journal:  Saudi Pharm J       Date:  2009-12-24       Impact factor: 4.330

10.  Successful treatment of hepatitis B-associated leukocytoclastic vasculitis with lamivudine treatment in a child patient.

Authors:  Ozge Surmali Onay; Esra Baskin; Figen Ozçay; Engin Melek; Oguz Canan; Banu Bilezikçi
Journal:  Rheumatol Int       Date:  2007-01-25       Impact factor: 3.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.